Winrevair 45 mg lyophilized powder for injection Images
Generic Name: sotatercept
This medication has been identified as Winrevair 45 mg lyophilized powder for injection. It is supplied by Merck.
Winrevair is used in the treatment of Pulmonary Arterial Hypertension and belongs to the drug class agents for pulmonary hypertension. Winrevair 45 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Winrevair
- Generic Name
- sotatercept
- Strength
- 45 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Agents for pulmonary hypertension
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- National Drug Code (NDC)
- 00006-5090
More about Winrevair (sotatercept)
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- FDA approval history
- Drug class: agents for pulmonary hypertension
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
